May 21, 2019
The Alliance Office of the Group Chair, Alliance Chicago Office, and the Alliance Statistics and Data Center will be closed on Monday, May 27 in observance of Memorial Day. Alliance Biorepositories and McKesson's Clinical Research Services will also be closed on Monday, May 27. For specific details, review the McKesson memo, BioMS holiday schedule or contact the Clinical Research Services team at 800-693-4903 or clinicalr
May 20, 2019
Anthony Jaslowski, MD, will serve as new Chair of the Alliance Constitution and Bylaws Committee. He succeeds Bruce A. Peterson, MD, of the University of Minnesota/Masonic Cancer Center. Dr. Jaslowski is the Principal Investigator of the Wisconsin NCI Community Oncology Research Program and Medical Director of HSHS St. Vincent Cancer Research Institute. He is also Chair of the Department of Oncology and Cancer Committee at Green Bay
May 17, 2019
Alliance A091802: Phase II randomized trial of avelumab plus cetuximab versus avelumab alone in advanced cutaneous squamous cell carcinoma of the skin (cSCC)
Overview: Alliance investigator Dan P. Zandberg, MD, of the University of Pittsburgh Medical Center Hillman Cancer Center, leads this phase II Alliance trial looks at how well avelumab with or without cetuximab work in treating patients with skin squamous cell cancer that h
